IFNα-2b is clinically approved to treat chronic hepatitis B, hairy cell leukemia, malignant melanoma, follicular lymphoma, and chronic and acute hepatitis C. IFNα has also been utilized in the treatment of other cancer types. The gene discussed is IFNA2; the disease is melanoma.